Cardiac autonomic denervation in diabetes mellitus

Circulation: Cardiovascular Imaging

Volumn 4, Issue 2, 2011, Pages 79-81

  Hage, Fadi G ^a,b   Iskandrian, Ami E ^a  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Diabetes mellitus; Editorials; Heart failure; Meta iodobenzylguanidine

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; CARBON 11; HYDROXYEPHEDRINE; INSULIN; ORAL ANTIDIABETIC AGENT; TRACER; UNCLASSIFIED DRUG;

AUTONOMIC DENERVATION; AUTONOMIC DYSFUNCTION; COLD PRESSOR TEST; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; DIABETES MELLITUS; DISEASE COURSE; EDITORIAL; HEART DENERVATION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; HYPERTENSION; ISOTOPE LABELING; ORTHOSTATIC HYPOTENSION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC TONE; TACHYCARDIA;

3-IODOBENZYLGUANIDINE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DISEASE PROGRESSION; HEART; HEART FAILURE; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 80051893823     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.111.963967     Document Type: Editorial

References (22)

1. Braun OO, Insel PA. The best "model system" for human (coronary arteries) is human. J Am Coll Cardiol. 2009;54:1146-1148.
2. Zheng M, Zhu W, Han Q, Xiao RP. Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling. Pharmacol Ther. 2005;108:257-268. (Pubitemid 41691867)
3. Baumgart D, Haude M, Gorge G, Liu F, Ge J, Grosse-Eggebrecht C, Erbel R, Heusch G. Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries. Circulation. 1999;99:2090-2097. (Pubitemid 29196791)
4. Sisson JC, Wieland DM. Radiolabeled meta-iodobenzylguanidine: pharmacology and clinical studies. Am J Physiol Imaging. 1986;1:96-103. (Pubitemid 17188385)
5. Ji SY, Travin MI. Radionuclide imaging of cardiac autonomic inner-vation. J Nucl Cardiol. 2010;17:655-666.
6. 123I-mIBG scintigra-phy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials. J Nucl Cardiol. 2009;16:113-121.
7. Fallavollita JA, Canty JM Jr. Dysinnervated but viable myocardium in ischemic heart disease. J Nucl Cardiol. 2010;17:1107-1115.
8. Di Carli MF, Bianco-Batlles D, Landa ME, Kazmers A, Groehn H, Muzik O, Grunberger G. Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation. 1999;100:813-819. (Pubitemid 29398878)
9. Burke MN, McGinn AL, Homans DC, Christensen BV, Kubo SH, Wilson RF. Evidence for functional sympathetic reinnervation of left ventricle and coronary arteries after orthotopic cardiac transplantation in humans. Circulation. 1995;91:72-78.
10. Di Carli MF, Tobes MC, Mangner T, Levine AB, Muzik O, Chakroborty P, Levine TB. Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med. 1997;336:1208-1215. (Pubitemid 27183650)
11. Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BL. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J. 2008;29: 1147-1159. (Pubitemid 351844881)
12. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, Agostini D, Weiland F, Chandna H, Narula J. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010;55: 2212-2221.
13. Gerson MC, Caldwell JH, Ananthasubramaniam K, Clements IP, Henzlova MJ, Amanullah A, Jacobson AF. Influence of diabetes mellitus on prognostic utility of imaging of myocardial sympathetic innervation in heart failure patients. Circ Cardiovasc Imaging. 2011;4:87-93
14. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007;115:3213-3223. (Pubitemid 47012236)
15. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Fra-mingham study. JAMA. 1979;241:2035-2038. (Pubitemid 9228506)
16. Macdonald MR, Petrie MC, Hawkins NM, Petrie JR, Fisher M, McKelvie R, Aguilar D, Krum H, McMurray JJ. Diabetes, left ventricular systolic dysfunction, and chronic heart failure. Eur Heart J. 2008;29:1224-1240. (Pubitemid 351768135)
17. Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbely A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echo-cardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;28:2539-2550. (Pubitemid 47614269)
18. Stevens MJ, Dayanikli F, Raffel DM, Allman KC, Sandford T, Feldman EL, Wieland DM, Corbett J, Schwaiger M. Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. J Am Coll Cardiol. 1998;31:1575-1584. (Pubitemid 28273301)
19. Tamaki S, Yamada T, Okuyama Y, Morita T, Sanada S, Tsukamoto Y, Masuda M, Okuda K, Iwasaki Y, Yasui T, Hori M, Fukunami M. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion. J Am Coll Cardiol. 2009;53:426-435.
20. Hage FG, Iskandrian AE. Heart rate response during vasodilator stress myocardial perfusion imaging: mechanisms and implications. J Nucl Cardiol. 2010;17:536-539.
21. Hage FG, Perry G, Heo J, Iskandrian AE. Blunting of the heart rate response to adenosine and regadenoson in relation to hyperglycemia and the metabolic syndrome. Am J Cardiol. 2010;105:839-843.
22. Hage FG, Heo J, Franks B, Belardinelli L, Blackburn B, Wang W, Iskandrian AE. Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus. Am Heart J. 2009;157:771-776.